Periprosthetic Joint Infection of Shoulder Arthroplasties: Diagnostic and Treatment Options.

Biomed Res Int

Department of Joint Replacement, General and Rheumatic Orthopaedics, Orthopaedic Clinic Markgröningen gGmbH, Kurt-Lindemann-Weg 10, 71706 Markgröningen, Germany.

Published: August 2018

Periprosthetic joint infection (PJI) is one of the most frequent reasons for painful shoulder arthroplasties and revision surgery of shoulder arthroplasties. is one of the microorganisms that most often causes the infection. However, this slow growing microorganism is difficult to detect. This paper presents an overview of different diagnostic test to detect a periprosthetic shoulder infection. This includes nonspecific diagnostic tests and specific tests (with identifying the responsible microorganism). The aspiration can combine different specific and nonspecific tests. In dry aspiration and suspected joint infection, we recommend a biopsy. Several therapeutic options exist for the treatment of PJI of shoulder arthroplasties. In acute infections, the options include leaving the implant in place with open debridement, septic irrigation with antibacterial fluids like octenidine or polyhexanide solution, and exchange of all removable components. In late infections (more than four weeks after implantation) the therapeutic options are a permanent spacer, single-stage revision, and two-stage revision with a temporary spacer. The functional results are best after single-stage revisions with a success rate similar to two-stage revisions. For single-stage revisions, the microorganism should be known preoperatively so that specific antibiotics can be mixed into the cement for implantation of the new prosthesis and specific systemic antibiotic therapy can be applied to support the surgery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750516PMC
http://dx.doi.org/10.1155/2017/4582756DOI Listing

Publication Analysis

Top Keywords

shoulder arthroplasties
16
joint infection
12
periprosthetic joint
8
therapeutic options
8
single-stage revisions
8
infection
5
shoulder
5
infection shoulder
4
arthroplasties
4
arthroplasties diagnostic
4

Similar Publications

Background: Shoulder arthroplasty is increasingly performed for shoulder conditions such as arthritis, rotator cuff arthropathy, and traumatic injuries. Registries and other compilations of patient data provide the opportunity to detect meaningful differences in outcomes between alternative techniques and implants. A wide range of outcome measurements are reported after shoulder arthroplasty, but the sample sizes needed to identify meaningful differences has not been studied systematically.

View Article and Find Full Text PDF

Background: Reverse shoulder arthroplasty (RSA) is increasingly used in the treatment of proximal humerus fractures (PHFs) with reliable clinical improvement. Lateralized RSA implants have conferred superior outcomes compared with the original Grammont design in patients with nontraumatic indications. However, in the setting of a PHF, lateralized components can place increased tension across the tuberosity fracture site and potentially compromise tuberosity healing and outcomes.

View Article and Find Full Text PDF

Background: Patient-reported outcome measures are a valuable tool to evaluate an intervention from a patient's perspective. Previous evidence shows that, while resident involvement may increase operative times, it does not affect complications or patient-reported outcomes. This study sought to assess the impact of a new residency program on patient-reported outcome measures, operative time, and complication rates in total shoulder arthroplasty.

View Article and Find Full Text PDF

Purpose: If surgery is indicated for elderly patients suffering a proximal humerus fracture, reverse fracture arthroplasty became the preferred type of treatment due to its good and reliable outcomes over the last decade. Surgeons could choose from a wide range of implants and up to now there was no evaluation, if a change of the manufacturer affects patients` outcome.

Methods: The last 100 patients before and the first 100 after manufacturer change in reverse fracture arthroplasty were evaluated at a level one trauma center, all treated by only 3 senior shoulder surgeons.

View Article and Find Full Text PDF

Background: Reverse (RTSA) and anatomic total shoulder arthroplasty (ATSA) are the gold standard surgical treatments for symptomatic glenohumeral osteoarthritis (OA). Typically, these procedures are pursued after exhausting medical management and non-arthroplasty procedures. There is little reliable evidence focused on non-arthroplasty treatments for glenohumeral OA, although their use is widespread.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!